Slide 1: The beat of life
For personal use only Company Presentation | May 2019 The beat of life ASX:HMD Leading Pregnancy Home Care 2018 HeraMED Ltd. © 2019
Slide 2: Disclaimer
Disclaimer This document contains a general summary of the company and is provided for information purposes only. For full details please review the Prospectus issued on 23 November 2018 For personal use only by HeraMED Limited ACN 626 295 314 (HeraMED) - https://www.asx.com.au/asxpdf/20181210/pdf/4
Slide 3: Leading Pregnancy Home Care
Leading Pregnancy Home Care For personal use only The World’s Most Advanced, Smart, Medical Grade, Home Pregnancy Management Platform Improving Mother & Baby Wellness Empowering Personalised, Proactive Care Reshaping Doctor/ Patient Relationship Providing Better Care at Lower Cost 3 Leading Pregnanc
Slide 4: Company overview
Company overview For personal use only • HeraMED • Distribution Network reshaping the pregnancy experience Building global distribution solving challenges associated with obsolete, episodic and visit-centric with best in class partners, company receiving purchase orders over several solutions, lack
Slide 5: Achievements since listing
Achievements since listing Considerable progress in commercial and regulatory efforts For personal use only HeraMED Completes Major Brazilian Health Dr Arturo Weschler MD Meerkats Partners for HeraMED Expands Over-Subscribed $6 Care Group Places Initial Appointed to Lead HeraBEAT Australian European
Slide 6: Corporate overview
Corporate overview For personal use only Corporate overview: Major shareholders: ASX code: HMD Holley Pharma Company 10.81% Shares on issue: 87.5m David Groberman 9.14% Total holdings: 114.8m (fully diluted) Tal Slonim 9.14% Market capitalisation: A$21.88m (12 May 2019) The Mayo Clinic 0.85% (@0.24
Slide 7: Ongoing pregnancy care issues
Ongoing pregnancy care issues The pregnancy experience hasn’t changed since the 50’s For personal use only DOCTORS/ PROVIDERS EXPECTING MOTHERS Shortage of fundamental services 14+ clinical sessions per pregnancy Lack of time and attention Loss of time away from work / child care Low reliability of
Slide 8: An end-to-end medical grade solution
An end-to-end medical grade solution Data and technology pregnancy home care is the future For personal use only PROVIDING CONTINUOUS TRACKING AND TREND BASED ANALYSIS Affordable Continuous Home use Accurate Technology Personalized Accessible Connected Friendly Reliable Data Driven Empowering 8 Lead
Slide 9: Large, addressable and recurring market
Large, addressable and recurring market* For personal use only “70% prefer using a digital The cumulative costs of childbirth is estimated at well over USD 50 billion annually in the U.S. alone $50 solution to monitor their billion health metrics at home.” Source: The New York Times, June 2013 Globa
Slide 10: Product and service offering
Product and service offering For personal use only 2019 2020 2021 HeraBEAT HeraCARE Orion AI Proprietary Fetal Heart Rate Pregnancy Management A.I. Powered Pregnancy Home Monitoring Device Platform & Service Monitoring Analysis US$299 MSRP US$69 Monthly Home US$4.90 (Monthly) Professional US$1.90 (P
Slide 11: HeraBEAT – revolutionising monitoring
HeraBEAT – revolutionising monitoring For personal use only The smart foetal heart rate monitor • Multi-sensor, medical grade fetal heart rate monitoring at home. • Clinical proven and approved by regulatory bodies including TGA (Australia), CE (Europe), MOH (India) and AMAR (Israel). • FDA 510K pro
Slide 12: Proprietary technology
Proprietary technology Hardware, Sensor IP and For personal use only anticipated features Pending Software and Algorithm IP 13 patents Foetal HR Hospital Quality Optimized Foetal Strip Doppler Maternal HR “Smart Search” Optical Sensor For Foetal HR Data Sharing Hypersensitive HIPAA-Compliance Ultras
Slide 13: HeraBEAT – Competitive edge
HeraBEAT – Competitive edge Considerably more advanced than existing offerings For personal use only Ultra Wide Smart Detection Guided Search Beam Doppler Fetal | Maternal Supporting App VS. Narrow Beam False Positive No Guidance Confusion Offline Fetal | Maternal 13 Leading Pregnancy Home Care © 20
Slide 14: Providing a hospital grade standard for home
Providing a hospital grade standard for home External lab comparison with leading multinational, hospital grade monitoring machine For personal use only 210 190 170 Fetal Heart rate [BPM] 150 130 Philips HeraBEAT 110 90 Hundreds of internal, external, bench and clinical tests prove HeraBEAT’s result
Slide 15: Endorsement from Industry Leaders
Endorsement from Industry Leaders “ “ “ For personal use only The HeraBEAT device is a The HeraBEAT device is by far OrionAI’s technology will potentially potential game-changer in the best home monitor that I enable the healthcare community empowering pregnant women to better have come across. The
Slide 16: Testimonials – Expectant Mums
Testimonials – Expectant Mums For personal use only “You can find the pulse of the baby, check that everything is okay, and send it off to your doctor; all in the palm of your hands, at home. It’s “ That moment when the heartbeat appears on the screen is a moment like no other. Finally, there’s an o
Slide 17: Current distribution footprint
Current distribution footprint Current distribution footprint For personal use only Near term markets entries Considerable progress made to date in expanding HMD’s distribution network. HeraMED has secured distribution UK USA Germany agreements in 5 countries. France Spain Turkey Discussions with me
Slide 18: Robust and replicable marketing strategy
Robust and replicable marketing strategy powered by For personal use only Strategising with best in class agencies in each country to ensure a defined plan for product launch Phase I Phase 2 Phase 3 Phase 4 Phase 5 ✔ ✔ ✔ ✔ ✔ Audience Engagement Media Creative Campaign Insight Strategy Planning Devel
Slide 19: Defined strategies outlined for Australia
Defined strategies outlined for Australia For personal use only • Deep, qualitative • Audience differentiated, • Social strategy to maximise audience knowledge contextual message strategy sharing of organic, user and market to drive whole conversation generated content, reducing segmentation pathway
Slide 20: Strong commercial growth pipeline globally
Strong commercial growth pipeline globally For personal use only 2020 2021 2019 2019-2020 2018 2019 US Global UK, Turkey EU Expansion Expansion Expansion Australia Mexico Israel ~ 45.1M ~ 5.7M ~ 4M ~ 310K ~ 4.2M Births/Ann ~ 180K Births/Ann Births/Ann Births/Ann Births/Ann Births/Ann • France 750K •
Slide 21: HeraCARE
HeraCARE Leading the digital transformation of prenatal care For personal use only • Data driven home care pregnancy management platform. • Preliminary pilot with Hapvida initiated 12 months ahead of schedule for 100 HeraBEAT devices. is one of Brazil’s largest medical organisations. (Circa. 100 Hos
Slide 22: HeraCARE integration scheme
HeraCARE integration scheme Providing peace of mind from a home care perspective For personal use only Blood Pressure Powered by Temperature HeraCARE Care Manager Platform Fetal Heart Rate Weight 22 Leading Pregnancy Home Care © 2019 HeraMED Ltd.
Slide 23: OrionAI
OrionAI For personal use only • Machine learning analysis for pregnancy monitoring. • Being developed in collaboration with esteemed US medical organisation, the Mayo Clinic. • Technology harnesses big data to analyse and evaluate thousands of record in real time, potentially allowing for unpreceden
Slide 24: Potential sector changing impact
Potential sector changing impact For personal use only Machine Learning Fully Automated Objective & Accurate Outperforming Experts Early Detection Machine learning, AI SaaS, cloud based, Immediate, objective Predicts physician Orion is trained to software, evaluating fully automated, easily and accu
Slide 25: The Mayo Clinic – R&D Collaborator
The Mayo Clinic – R&D Collaborator For personal use only • Mayo Clinic is one of the leading medical institutions in the world. • A non-profit medical practice and medical research group based in Minnesota. employs more than 4,500 physicians and scientists and 58,400 administrative and allied health
Slide 26: Global impact
Global impact Revolutionising pregnancy monitoring standards to significantly impact For personal use only pregnancy outcomes, preterm rates and related costs Reduce Diagnose Optimize Empower Early Costs Preterm Healthcare OB/GYNs Detection Births Standards Dramatic improvement ~45% of preterm to pr
Slide 27: Near term growth drivers
Near term growth drivers For personal use only HeraBEAT HeraCARE Orion AI • Ongoing hardware and functionality • Preliminary pilot trial with Hapvida - • Finalise clinical trials with the optimisation results expected by end of 2019 Mayo Clinic • Manufacturability and cost-reductions • Ongoing produ
Slide 28: David Groberman
For personal use only David Groberman CEO & Co-Founder Mobile +972-52-6991188 David@Hera-Med.com 28 Leading Pregnancy Home Care © 2019 HeraMED Ltd.
Slide 29: Appendix 1: Board of Directors
Appendix 1: Board of Directors Dr. Ron Weinberger – Non-Executive Chairman For personal use only Highly experienced business executive, with strong scientific background and international span| Ex president and CEO of Nanosonics Ltd. ASX: NAN, Mkt cap ~A$1.35Bn David Groberman – CEO, Co-Founder and
Slide 30: Appendix 2: Market segments
Appendix 2: Market segments Global vertical impact For personal use only HOSPITALS / CLINICS Reduce Unnecessary Clinic Visits Let Professionals Practice “Real” Medicine HOMECARE Increase Patient Improve Mother/Baby Wellness Satisfaction Empower Pregnant Woman & Reduce Anxiety Early Warning In Case O
Slide 31: DEMO
DEMO Machine Learning Analysis For For personal use only Pregnancy Monitoring Sample Case Studies Normal Contractions Hyper Stimulation Minimal FHRV Deceleration and Recuperation 31 Leading Pregnancy Home Care © 2019 HeraMED Ltd.
Slide 32: Appendix 4: References
Appendix 4: References For personal use only Slide 9: Wired – Liat Clark: https://www.wired.co.uk/article/doctors-replaced-with-machines The New York Times – Elisabeth Rosenthal: https://www.nytimes.com/2013/07/01/health/american-way-of-birth-costliest-in-the-world.html Zion Market Research – Global